alarm-ringing ambulance angle2 archive arrow-down arrow-left arrow-right arrow-up at-sign baby baby2 bag binoculars book-open book2 bookmark2 bubble calendar-check calendar-empty camera2 cart chart-growth check chevron-down chevron-left chevron-right chevron-up circle-minus circle city clapboard-play clipboard-empty clipboard-text clock clock2 cloud-download cloud-windy cloud clubs cog cross crown cube youtube diamond4 diamonds drop-crossed drop2 earth ellipsis envelope-open envelope exclamation eye-dropper eye facebook file-empty fire flag2 flare foursquare gift glasses google graph hammer-wrench heart-pulse heart home instagram joystick lamp layers lifebuoy link linkedin list lock magic-wand map-marker map medal-empty menu microscope minus moon mustache-glasses paper-plane paperclip papers pen pencil pie-chart pinterest plus-circle plus power pushpin question rain reading receipt recycle reminder sad shield-check smartphone smile soccer spades speed-medium spotlights star-empty star-half star store sun-glasses sun tag telephone thumbs-down thumbs-up tree tumblr twitter user users wheelchair write yelp youtube

Self-tinting contact lenses are on their way

Over the years, we’ve gotten pretty used to glasses with photochromic lenses, which automatically darken when exposed to bright light. This week, Johnson & Johnson Vision announced the upcoming availability of its self-tinting contact lenses. Developed in partnership with Transitions Optical, the contacts are known as Acuvue Oasys With Transitions. They’ll still correct vision problems just like normal prescription contacts, but will also “quickly and seamlessly adjust from clear to dark in response to changing light conditions,” filtering blue light and blocking UV rays. And no, they won’t darken while driving in your car.

That said, Johnson & Johnson does stress that they aren’t intended to be a replacement for sunglasses, as they don’t cover the entire eye.

According to the company, the lenses have been in development for over a decade, and have been the subject of numerous clinical trials involving over 1,000 people. Now, they’ve achieved clearance from the US Food and Drug Administration for the attenuation of bright light.

The two-week reusable Acuvue Oasys With Transitions contacts should be commercially available in the first half of next year.